{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:02:35Z","timestamp":1790622155053,"version":"4.1.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700890, 82171106"],"award-info":[{"award-number":["81700890, 82171106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic rhinosinusitis with nasal polyps (CRSwNP) is often characterized by recurrent nasal polyp (NP) growth following surgical removal, but the mechanisms are still not clear. This study aimed to investigate the expression of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) receptor on NP and the role it plays in eosinophil inflammation and polyp recurrence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Forty-one CRSwNPs patients and seventeen controls were enrolled in this study. mRNA was extracted from nasal tissues and evaluated for expression of CRTH2. Immunofluorescence staining was performed to confirm the distribution and expression of CRTH2 protein. CRTH2 expression on peripheral blood eosinophils was quantified by flow cytometry. The eosinophil count and clinical implications were also evaluated and their correlations with CRTH2 expression were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nasal polyps displayed increased expression of CRTH2 in mRNA level compared with control samples, with the highest expression observed in recurrent NP. Immunofluorescence confirmed over-expression of CRTH2 in recurrent NP and this was independent of the concurrent presence of asthma. CRTH2 expression was positively correlated with tissue eosinophil number (Spearman\u2019s \u03c1=0.69,<jats:italic>P<\/jats:italic>&amp;lt;0.001) and the postoperative sino-nasal outcome test-22 (SNOT-22) score (Spearman\u2019s \u03c1=0.67,<jats:italic>P<\/jats:italic>&amp;lt;0.001). Receiver operating characteristic (ROC) curves revealed CRTH2 was more predictive for NP recurrence compared to either eosinophil number and concomitant asthma, with an area under the ROC curve of 0.9107.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The over-expression of CRTH2 in recurrent nasal polyps correlates with greater eosinophilic inflammation and poor prognosis which is independent of concomitant asthma.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1046426","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T06:31:07Z","timestamp":1668753067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Over-expression of CRTH2 indicates eosinophilic inflammation and poor prognosis in recurrent nasal polyps"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenhui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica G.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Borish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","article-title":"European Position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.07.002","article-title":"Eosinophilic chronic rhinosinusitis","volume":"68","author":"Fujieda","year":"2019","journal-title":"Allergol Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13536","article-title":"Comorbidities associated with eosinophilic chronic rhinosinusitis: A systematic review and meta-analysis","volume":"45","author":"McHugh","year":"2020","journal-title":"Clin Otolaryngol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.02.020","article-title":"Medical management strategies in acute and chronic rhinosinusitis","volume":"8","author":"Cho","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22194","article-title":"High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: A systematic review and meta-analysis","volume":"8","author":"McHugh","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21885","article-title":"The prognostic role of serum eosinophil and basophil levels in sinonasal polyposis","volume":"7","author":"Brescia","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24154","article-title":"Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil","volume":"123","author":"Ikeda","year":"2013","journal-title":"Laryngoscope"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1945892420961964","article-title":"Surgery in nasal polyp patients: Outcome after a minimum observation of 10 years","volume":"35","author":"Vlaminck","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/lary.27564","article-title":"Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size","volume":"129","author":"Laidlaw","year":"2019","journal-title":"Laryngoscope"},{"key":"B10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jaci.2017.02.030","article-title":"Mast cell-derived prostaglandin D2 attenuates anaphylactic reactions in mice","volume":"140","author":"Nakamura","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.148.11.3536","article-title":"Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils","volume":"148","author":"Raible","year":"1992","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.5.2277","article-title":"Cutting edge: Differential production of prostaglandin D2 by human helper T cell subsets","volume":"164","author":"Tanaka","year":"2000","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(85)90168-6","article-title":"Production of prostaglandin D2 by murine macrophage cell lines","volume":"30","author":"McGuire","year":"1985","journal-title":"Prostaglandins"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jaci.2016.04.042","article-title":"Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease","volume":"138","author":"Feng","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2011.07.017","article-title":"IFN-gamma and TNF-alpha potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor","volume":"11","author":"El-Shazly","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0777-2","article-title":"Targeting the PGD2\/CRTH2\/DP1 signaling pathway in asthma and allergic disease: Current status and future perspectives","volume":"77","author":"Kupczyk","year":"2017","journal-title":"Drugs"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60239-6","article-title":"Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa","volume":"102","author":"Shirasaki","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-412","article-title":"Meta-analysis of competitive antagonists in asthma treatment","volume":"10","author":"Lei","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12931-018-0912-y","article-title":"Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: A meta-analysis and systematic review","volume":"19","author":"Yang","year":"2018","journal-title":"Respir Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S2213-2600(16)30179-5","article-title":"Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: A single-centre, randomised, double-blind, parallel-group, placebo-controlled trial","volume":"4","author":"Gonem","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S2213-2600(20)30412-4","article-title":"Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): Two phase 3 randomised controlled trials","volume":"9","author":"Brightling","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11882-021-01017-8","article-title":"Efficacy and safety of prostaglandin D2 receptor 2 antagonism with fevipiprant for patients with asthma: A systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Yang","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2017.38.4034","article-title":"A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma","volume":"38","author":"Miller","year":"2017","journal-title":"Allergy Asthma Proc"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000155743","article-title":"Expression and characterization of PGD2 receptors in chronic rhinosinusitis: Modulation of DP and CRTH2 by PGD2","volume":"148","author":"Yamamoto","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.prostaglandins.2003.12.002","article-title":"Expression of prostaglandin d synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa","volume":"73","author":"Nantel","year":"2004","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B26","first-page":"3","article-title":"European Position paper on rhinosinusitis and nasal polyps 2012","volume":"23","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/all.15168","article-title":"Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota","volume":"77","author":"Zhao","year":"2022","journal-title":"Allergy."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MCP.0000000000000125","article-title":"The revised 2014 GINA strategy report: Opportunities for change","volume":"21","author":"Boulet","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"B29","article-title":"Staging in rhinosinusitus","volume":"31","author":"Lund","year":"1993","journal-title":"Rhinology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25318","article-title":"The predictive value of the preoperative sinonasal outcome test-22 score in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis","volume":"125","author":"Hopkins","year":"2015","journal-title":"Laryngoscope"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4193\/Rhino15.284","article-title":"Using postoperative SNOT-22 to help predict the probability of revision sinus surgery","volume":"54","author":"Rudmik","year":"2016","journal-title":"Rhinology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.anai.2022.01.007","article-title":"Lower viral loads in subjects with rhinovirus-challenged allergy despite reduced innate immunity","volume":"128","author":"Feng","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.035","article-title":"Prostaglandin D(2) pathway upregulation: Relation to asthma severity, control, and TH2 inflammation","volume":"131","author":"Fajt","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2007.07.036","article-title":"Histological and immunological features of non-eosinophilic nasal polyps","volume":"137","author":"Kim","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2015.29.4231","article-title":"Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population","volume":"29","author":"Lou","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/1945892419860634","article-title":"Differential expression of extracellular matrix components in nasal polyp endotypes","volume":"33","author":"Feng","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02204.x","article-title":"CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE\/anti-IgE treated nasal polyp tissue","volume":"65","author":"Perez-Novo","year":"2010","journal-title":"Allergy"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/all.13974","article-title":"Evidence for the induction of Th2 inflammation by group 2 innate lymphoid cells in response to prostaglandin D2 and cysteinyl leukotrienes in allergic rhinitis","volume":"74","author":"Tojima","year":"2019","journal-title":"Allergy"},{"key":"B39","doi-asserted-by":"publisher","first-page":"102474","DOI":"10.1016\/j.plefa.2022.102474","article-title":"Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis","volume":"184","author":"Nordstrom","year":"2022","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000327257","article-title":"Role of prostaglandin D2 receptor CRTH2 in sustained eosinophil accumulation in the airways of mice with chronic asthma","author":"Kagawa","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900646","article-title":"CD69 controls the pathogenesis of allergic airway inflammation","volume":"183","author":"Miki-Hosokawa","year":"2009","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cea.12462","article-title":"Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia","volume":"45","author":"Ho","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"B43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13223-017-0183-z","article-title":"Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from phase 2 and phase 3 randomized, double-blind, placebo- and active-referenced studies","volume":"13","author":"Ratner","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.10.013","article-title":"Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis","volume":"133","author":"Krug","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/all.12042","article-title":"The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial","volume":"67","author":"Horak","year":"2012","journal-title":"Allergy"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00670-2017","article-title":"Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids","volume":"50","author":"Bateman","year":"2017","journal-title":"Eur Respir J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.jaci.2021.12.759","article-title":"Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)","volume":"149","author":"Gevaert","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1046426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T23:46:52Z","timestamp":1678664812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1046426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2022.1046426"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1046426","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"article-number":"1046426"}}